SCHEDULE: Cowen Financial Products Divests Stoke Therapeutics Stake

Cowen Financial Products LLC has reported a complete divestment of its beneficial ownership in Stoke Therapeutics Inc common stock, transferring it to an affiliated entity, The Toronto Dominion Bank.

Summary

• Cowen Financial Products LLC, the reporting entity, no longer holds any beneficial ownership in Stoke Therapeutics Inc common stock.
• All beneficial ownership was transferred to The Toronto Dominion Bank, an affiliated entity, between the event date (September 30, 2025) and the filing date (November 13, 2025).
• The reporting person's beneficial ownership is now 0 shares, representing 0% of the class.

Sentiment

Score: 5

Explanation: Neutral, as it reports a factual change in ownership without indicating positive or negative performance for the issuer. The transfer to an affiliate suggests a strategic internal move rather than a negative external divestment.

Positives

• The transfer of ownership to an affiliated entity, The Toronto Dominion Bank, suggests a strategic realignment within the broader corporate structure rather than an outright sale to an unrelated third party.

Negatives

• Cowen Financial Products LLC no longer holds any beneficial ownership in Stoke Therapeutics Inc, indicating a complete exit from this specific holding for the reporting entity.

Risks

• The filing itself does not detail specific risks related to Stoke Therapeutics Inc, but rather reports a change in beneficial ownership. The primary risk for Cowen Financial Products LLC is the complete divestment of its stake, meaning it no longer benefits from any potential upside in Stoke Therapeutics.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding Stoke Therapeutics Inc or Cowen Financial Products LLC's future investment strategies beyond the reported ownership change.

Industry Context

This filing is a routine disclosure of a change in beneficial ownership, reflecting an internal transfer within Cowen's affiliated entities. It does not provide broader industry trends or competitive analysis for Stoke Therapeutics Inc, which operates in the biotechnology sector.

Related Party Transactions

• Beneficial ownership of Stoke Therapeutics Inc common stock was transferred from Cowen Financial Products LLC to The Toronto Dominion Bank, an affiliated entity.

Stakeholder Impact

• Shareholders of Stoke Therapeutics Inc: The change in beneficial ownership from Cowen Financial Products LLC to an affiliated entity, The Toronto Dominion Bank, means that the overall institutional holding might remain stable, but the specific entity holding the shares has changed. This is generally a neutral event unless the new holder has a significantly different investment strategy.
• Cowen Financial Products LLC: The entity no longer holds a direct stake, impacting its exposure to Stoke Therapeutics Inc.
• The Toronto Dominion Bank: Now holds the beneficial ownership, increasing its direct exposure to Stoke Therapeutics Inc.

Key Dates

Keywords

Stoke Therapeutics Inc, Cowen Financial Products LLC, Schedule 13G, Beneficial Ownership, Divestment, Common Stock, The Toronto Dominion Bank, SEC Filing